Publication | Closed Access

The DNA methyltransferase inhibitors azacitidine, decitabine and zebularine exert differential effects on cancer gene expression in acute myeloid leukemia cells

Dna Methyltransferase InhibitorsChromatinHematological MalignancyCancer Gene ExpressionDifferential EffectsMedicineMixed-phenotype Acute LeukemiaEpigenetic ChangeMalignant Blood DisorderRadiation OncologyOncologyCell BiologyEpigeneticsCancer ResearchMyeloid Neoplasia